ABOT Pharmaceuticals: Major
Health Technology
Mkt Cap
86.6B
P/E (TTM)
10.43
EPS
81.37
ROE
28.59%
Div Yield
4.52%
5 years
FY2025FY2024FY2023FY2022FY2021
Profitability
Return on Equity (ROE)28.79%24.95%1.48%17.44%36.22%
Return on Assets (ROA)18.79%13.95%0.73%9.52%22.20%
Return on Invested Capital28.60%24.90%1.47%17.30%35.41%
Gross Margin35.08%27.71%20.44%28.17%36.06%
Operating Margin18.57%12.25%3.51%12.36%19.09%
EBITDA Margin14.86%6.36%15.29%22.04%
Net Margin10.57%7.68%0.47%6.10%14.02%
Pre-Tax Margin17.90%13.23%3.68%12.48%19.76%
Liquidity
Current Ratio2.321.991.381.501.97
Quick Ratio1.340.950.560.811.16
Leverage
Debt / Equity0.020.000.010.010.01
Debt / Assets0.010.000.000.010.01
LT Debt / Equity0.010.000.000.010.01
LT Debt / Assets0.010.000.000.000.00
Net Debt-12.85B-6.13B-4.88B-8.54B-8.39B
Total Debt487.98M52.23M158.22M247.29M227.69M
Efficiency
Asset Turnover1.781.821.561.561.58
Inventory Turnover3.873.813.724.024.07
Per Share
Book Value Per Share242.33186.28174.73177.27
Tangible Book Per Share242.32186.16174.45176.77
Cash Per Share63.1551.4589.8088.04
Total Debt Per Share0.531.622.532.33
Working Capital Per Share118.5065.0074.1092.84
Shares & Market
Total Shares Outstanding97,900,30297,900,30297,900,30297,900,302
Market Cap121.19B45.05B45.36B70.24B
Enterprise Value115.06B40.18B36.81B61.85B
Employees1,4061,4301,4631,469
Shareholders3,0153,0153,0153,0153,015